Edwards Lifesciences Corporation Common Stock vs MetLife Inc. Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while MetLife Inc. Common Stock trades at $98.97 (market cap $62.58B). The key difference: MetLife Inc. Common Stock is the larger of the two by market cap, and MetLife Inc. Common Stock pays a 2.41% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | MET | |
|---|---|---|
Market Cap | $48.56B | $62.58B |
Volume | 6,520,488 | 3,009,466 |
Sector | Health | Financials |
52-Week High | $95.18 | $99.95 |
52-Week Low | $72.65 | $67.70 |
Enterprise Value | $45.01B | $83.50B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 2.41% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →MetLife provides insurance, annuities, employee benefits, and asset management services. Its products serve individuals, employers, and institutions.
Read more on MET →